CD23 role during inflammatory diseases was first suggested in rheumatoid arthritis by the ability of anti-mouse CD23 antibody to decrease cellular infiltration of the synovial sublining layer and the destruction of cartilage, in mice with collagen-induced arthritis [13]. This evidence concerns the gene FCER2 and rheumatoid arthritis.